-
1
-
-
1642453729
-
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection
-
Squires K, Pozniak AL, Pierone G, et al. (2003). Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection. Ann Intern Med. 2003;139:313-320.
-
(2003)
Ann Intern Med
, vol.2003
, Issue.139
, pp. 313-320
-
-
Squires, K.1
Pozniak, A.L.2
Pierone, G.3
-
2
-
-
3042848853
-
Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral- naïve patients: A three-year randomized trial
-
Gallant JE, Staszeweski S, Pozniak AL, et al. (2004). Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral- naïve patients: A three-year randomized trial. JAMA. 2004;292:191-201.
-
(2004)
JAMA
, vol.2004
, Issue.292
, pp. 191-201
-
-
Gallant, J.E.1
Staszeweski, S.2
Pozniak, A.L.3
-
3
-
-
30944468562
-
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
-
Gallant JE, DeJesus E, Arribas JR, et al. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006;354:251-260.
-
(2006)
N Engl J Med
, vol.354
, pp. 251-260
-
-
Gallant, J.E.1
DeJesus, E.2
Arribas, J.R.3
-
4
-
-
0038178864
-
Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity
-
Perazella MA. Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci. 2003;325(6):349-362.
-
(2003)
Am J Med Sci
, vol.325
, Issue.6
, pp. 349-362
-
-
Perazella, M.A.1
-
5
-
-
33846420624
-
Functional involvement of multidrug-resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir
-
Imoka A, Kusuhara H, Adachi M, et al. (2007). Functional involvement of multidrug-resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol. 2007;71:619-627.
-
(2007)
Mol Pharmacol
, vol.2007
, Issue.71
, pp. 619-627
-
-
Imoka, A.1
Kusuhara, H.2
Adachi, M.3
-
6
-
-
0037447180
-
Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi Syndrome, and nephrogenic diabetes insipdus
-
Karras A, Lafaurie M, Furco A, et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi Syndrome, and nephrogenic diabetes insipdus. Clin Infect Dis. 2003;36:1070-1073.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 1070-1073
-
-
Karras, A.1
Lafaurie, M.2
Furco, A.3
-
7
-
-
16844370820
-
Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment
-
Gallant JE, Parish MA, Keruly JC, Moore RD. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin Infect Dis. 2005;40:1194-1198.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 1194-1198
-
-
Gallant, J.E.1
Parish, M.A.2
Keruly, J.C.3
Moore, R.D.4
-
8
-
-
0036953640
-
Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity
-
Coca S, Perazella MA. Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity. Am J Med Sci. 2002;324(6): 342-344.
-
(2002)
Am J Med Sci
, vol.324
, Issue.6
, pp. 342-344
-
-
Coca, S.1
Perazella, M.A.2
-
10
-
-
33749531758
-
Mechanism of acute renal tubular efflux of tenofovir
-
Ray SA, Cihlar T, Robinson KL, et al. Mechanism of acute renal tubular efflux of tenofovir. Anitmicrob. Agents Chemother. 2006;50(10):3297-3304.
-
(2006)
Anitmicrob. Agents Chemother
, vol.50
, Issue.10
, pp. 3297-3304
-
-
Ray, S.A.1
Cihlar, T.2
Robinson, K.L.3
-
11
-
-
34247528947
-
Unlikely association of multidrug-resistance protein-2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events
-
Ray AS, Cihlar T. Unlikely association of multidrug-resistance protein-2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events. CID. 2007;195:1389.
-
(2007)
CID
, vol.195
, pp. 1389
-
-
Ray, A.S.1
Cihlar, T.2
-
12
-
-
36849050513
-
Role of intestinal absorption in increased tenofovir exposure when tenofovir disoproxil fumarate is co-administered with atazanavir or lopinavir/ritonavir
-
Abstract, Lisbon;
-
Ray AS, et al. Role of intestinal absorption in increased tenofovir exposure when tenofovir disoproxil fumarate is co-administered with atazanavir or lopinavir/ritonavir. HIV Pharmacology Workshop. Abstract #49. Lisbon; 2006.
-
(2006)
HIV Pharmacology Workshop
, Issue.49
-
-
Ray, A.S.1
-
13
-
-
33847001598
-
Multidrug resistance protein-2 (MRP-2) inhibition by ritonavir (RTV) increases tenofovir (TDF)-associated cytotoxicity
-
Poster 2.16, Quebec, Canada;
-
Louie SG, Lam JT, Neely MN, Beringer P. Multidrug resistance protein-2 (MRP-2) inhibition by ritonavir (RTV) increases tenofovir (TDF)-associated cytotoxicity. Poster 2.16. Program and abstracts of the Sixth International Workshop on Clinical Pharmacology of HIV Therapy. Quebec, Canada; 2005.
-
(2005)
Program and abstracts of the Sixth International Workshop on Clinical Pharmacology of HIV Therapy
-
-
Louie, S.G.1
Lam, J.T.2
Neely, M.N.3
Beringer, P.4
-
14
-
-
33845226137
-
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy
-
Izzedine H, Hulot JS, Villard E, et al. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. JID. 2006;194:1481-1491.
-
(2006)
JID
, vol.194
, pp. 1481-1491
-
-
Izzedine, H.1
Hulot, J.S.2
Villard, E.3
-
15
-
-
10044236429
-
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently
-
Jones R, Stebbing J, Nelson M, et al. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently. J Acquir Immune Defic Syndr. 2004;37:1489-1495.
-
(2004)
J Acquir Immune Defic Syndr
, vol.37
, pp. 1489-1495
-
-
Jones, R.1
Stebbing, J.2
Nelson, M.3
|